文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

针对近期妊娠期糖尿病且产后糖耐量正常的亚洲女性预防产后2型糖尿病的生活方式干预:一项靶向产后生活方式项目的随机对照试验研究方案

Lifestyle intervention to prevent postpartum type 2 diabetes in Asian women with recent gestational diabetes and normal post-pregnancy glucose tolerance: study protocol for a randomized controlled trial with a targeted postpartum lifestyle programme.
PubMed 文献 · Trials · 2026-02-11

IHIPS研究为新加坡KK妇女儿童医院开展的单中心随机对照试验,计划招募200名产后8至12周、有妊娠期糖尿病史且早期产后糖耐量正常的女性,评估36个月随访期间2型糖尿病累积发病率。干预组接受包含可穿戴技术支持的个性化目标设定研讨会在内的多组分项目,对照组接受标准产后护理,并评估心脏代谢风险因素、身体活动、膳食摄入及成本效益。

要点

  • 针对有妊娠期糖尿病史且产后糖耐量正常的亚洲女性,评估生活方式干预对2型糖尿病累积发病率的影响。
  • 干预组接受多组分项目,包括可穿戴技术支持的个性化目标设定研讨会;对照组接受标准产后护理。
  • 主要结局为36个月随访期间2型糖尿病累积发病率,次要结局包括12、24、36个月糖代谢异常发病率及成本效益。

核心结论

  • IHIPS研究预期为开发早期产后、基于医院的生活方式干预提供见解,并有可能改善母亲及其婴儿的长期健康结局。

研究设计与样本

  • 单中心随机对照试验,在新加坡KK妇女儿童医院开展,计划招募200名产后8至12周的女性。

主要发现

  • 主要目的为评估36个月随访期间2型糖尿病的累积发病率。
  • 次要目的包括评估12、24和36个月随访时糖代谢异常(糖尿病前期和2型糖尿病)的发病率,以及监测6至36个月期间心脏代谢风险因素、身体活动和膳食摄入的纵向变化。
  • 将评估成本效益。
  • 干预组接受多组分项目,包括由可穿戴技术(如连续血糖监测仪和Fitbit追踪器)支持的个性化目标设定研讨会;对照组接受标准产后护理。
  • 所有参与者将提供血样并接受人体测量和身体成分测量,并完成评估膳食摄入、身体活动、健康相关生活质量及临床试验体验的自填问卷。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The primary aim of the Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS) study is to reduce the incidence of type 2 diabetes mellitus (T2DM) among women with a history of gestational diabetes mellitus (GDM) in their index pregnancy who demonstrate normal glucose tolerance in the early postpartum period. This is being evaluated through a single-centre randomized controlled trial (RCT) conducted at KK Women's and Children's Hospital (KKH) in Singapore. METHODS: The study aims to recruit 200 women between 8 and 12 weeks postpartum. The primary objective is to assess the cumulative incidence of T2DM over a 36-month follow-up period. Secondary objectives include evaluating the incidence of dysglycaemia (prediabetes and T2DM) at 12-, 24-, and 36-month follow-ups, as well as monitoring longitudinal changes in cardiometabolic risk factors, physical activity, and dietary intake from 6 to 36 months. Cost-effectiveness will also be assessed. Participants in the intervention group will receive a multi-component programme that includes personalized goal-setting workshops supported by wearable technologies, such as continuous glucose monitors and Fitbit trackers. The control group will receive standard postnatal care. All participants will provide blood samples and undergo anthropometric and body composition measurements. Participants will also complete self-administered questionnaires evaluating dietary intake, physical activity, health-related quality of life, and their experience with the clinical trial. DISCUSSION: The IHIPS study is expected to provide insights to guide the development of early postpartum, hospital-based lifestyle interventions, with the potential to improve long-term health outcomes for mothers and their infants. TRIAL REGISTRATION: ClinicalTrials.gov NCT05081037 . Registered on 06 September 2021, https://clinicaltrials.gov/study/NCT05081037 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Quah PL, Song H, Han WM, et al. Lifestyle intervention to prevent postpartum type 2 diabetes in Asian women with recent gestational diabetes and normal post-pregnancy glucose tolerance: study protocol for a randomized controlled trial with a targeted postpartum lifestyle programme. Trials. 2026. PMID: 41673699. doi:10.1186/s13063-026-09516-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。